Episode Details

We're joined by the Co-Founder of Dragonfly 44 Capital, Michael Brotherton. Michael has a good perspective on the psychedelics industry and plenty to discuss around the space including the research focus at the core of psychedelics and potential healing possible for those in need. We discuss recreational use vs healing and touch on human optimization uses as well. Dragonfly 44 Capital specializes in supporting the growth and development of the world’s strongest neuropsychiatry, mental healthcare, longevity, and wellness companies. dragonfly44.capital apt113.com